Schedule 13G ownership disclosure

DECIPHERA PHARMACEUTICALS IN

Security class unavailable · CUSIP: 24344T101

Event date: 2017-10-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,479,867
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-17-000056
Form type
SC 13G
Filer
Deciphera Pharmaceuticals, Inc.
CIK
CIK 1654151
Filed
Oct 11, 2017
Reporting period
Oct 02, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub